Modular Medical director granted 103 MODD shares

Volkart Carmen B reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Volkart Carmen B reported acquisition or exercise transactions in this Form 4 filing.

Modular Medical, Inc. director Carmen B. Volkart received a grant of 103 shares of Common Stock on March 31, 2026 as a compensation award. The shares were issued under the company’s Outside Director Compensation Plan and brought Volkart’s direct holdings to 806 shares. The share amounts reflect a 1-for-30 reverse stock split of the common stock that was effected on the same date.

Insider Trade Summary

Grant/Award: 103 shares

Grant/Award 1 txn

Insider Volkart Carmen B

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	103	$0.00	$0.00

Holdings After Transaction: Common Stock — 806 shares (Direct)

Footnotes (2)

1. F1. These shares were issued to the Reporting Person pursuant to the Issuer's Outside Director Compensation Plan.
2. F2. Share amount reflects the impact of a 1-for-30 reverse stock split of the Issuer's common stock effected on March 31, 2026.

Key Figures

Shares granted: 103 shares Grant price per share: $0.0000 per share Shares held after transaction: 806 shares +1 more

4 metrics

Shares granted 103 shares Common Stock grant to director on March 31, 2026

Grant price per share $0.0000 per share Compensation award under Outside Director Compensation Plan

Shares held after transaction 806 shares Director’s direct Common Stock holdings after grant

Reverse stock split ratio 1-for-30 Reverse split of common stock effected March 31, 2026

Key Terms

Outside Director Compensation Plan, reverse stock split, Common Stock, Grant, award, or other acquisition

4 terms

Outside Director Compensation Plan financial

"These shares were issued to the Reporting Person pursuant to the Issuer's Outside Director Compensation Plan."

reverse stock split financial

"Share amount reflects the impact of a 1-for-30 reverse stock split of the Issuer's common stock effected on March 31, 2026."

A reverse stock split reduces a company's number of outstanding shares while raising the price per share proportionally, so the total value of each investor's holding is unchanged; a 1-for-10 split turns 100 shares worth $1 each into 10 shares worth $10 each. Companies often do this to regain compliance with an exchange's minimum price rule or to attract investors who avoid very low-priced stocks.

Common Stock financial

"security_title: "Common Stock""

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

Grant, award, or other acquisition financial

"transaction_code_description: "Grant, award, or other acquisition""

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did the Modular Medical (MODD) Form 4 report for Carmen B. Volkart?

The Form 4 reports that director Carmen B. Volkart received 103 shares of Modular Medical Common Stock on March 31, 2026 as a compensation grant, increasing her direct holdings to 806 shares after the transaction, according to the company’s filing details.

Was the MODD insider transaction a purchase or a compensation grant?

The MODD insider transaction was a compensation grant, not a market purchase. Carmen B. Volkart received 103 Common Stock shares at a price of $0.0000 per share under the Outside Director Compensation Plan as part of her director compensation package.

How many Modular Medical (MODD) shares does Carmen B. Volkart hold after this grant?

After receiving the 103-share compensation award, Carmen B. Volkart directly holds 806 shares of Modular Medical Common Stock. This total reflects the impact of the company’s 1-for-30 reverse stock split that was effected on March 31, 2026, as disclosed.

What is the significance of the 1-for-30 reverse stock split for MODD shares?

The 1-for-30 reverse stock split consolidated every 30 shares of Modular Medical common stock into one share. The share amounts reported in Carmen B. Volkart’s Form 4, including the 103-share grant and 806 shares held after, already incorporate this reverse split adjustment.

Under what plan were the MODD shares granted to director Carmen B. Volkart?

The 103 shares of Modular Medical Common Stock granted to director Carmen B. Volkart were issued under the company’s Outside Director Compensation Plan. This plan provides equity-based awards as part of compensation for non-employee directors serving on the company’s board.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 04/08/2026 - 05:00 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Volkart Carmen B

(Last) (First) (Middle)

C/O MODULAR MEDICAL, INC.

10740 THORNMINT ROAD

(Street)

SAN DIEGO CALIFORNIA 92127

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Modular Medical, Inc. [ MODD ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/31/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/31/2026		A		103	A	(1)	806(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. These shares were issued to the Reporting Person pursuant to the Issuer's Outside Director Compensation Plan.

2. Share amount reflects the impact of a 1-for-30 reverse stock split of the Issuer's common stock effected on March 31, 2026.

	/s/ James Sullivan, Attorney in Fact for Carmen Volkart	04/08/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)